Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Expert Testimony Stricken in Patent Case

"However, could be atvantageous for the share price if PTSC filies earlier."

It all depends on what the 10Q looks like.

The SP will also have to contend with the big "Seller(s)" - If the 10Q is very positive, the Seller(s) will take this opportunity to do "a lot more dumping".

Share
New Message
Please login to post a reply